-
Studies have revealed that the prevalence of insomnia in patients with chronic schizophrenia is higher and related to cognitive impairment
Time of Update: 2023-02-03
The findings suggest that patients with chronic schizophrenia have a higher prevalence of insomnia compared to healthy people, and patients with insomnia have worse cognitive performance than those without insomnia.
-
December neurology guidelines and consensus, one article included in the guideline consensus
Time of Update: 2023-02-03
cn/guideline/27616Recommended reading ☟☟☟January| February| March| April| May| June| July| August| September| October|November03Consensuson the diagnosis, treatment and management of cognitive impairment after noveland spread of coronavirus disease 2019 (COVID-19) (referred to as "new coronary pneumonia") around the world has had a huge impact on the physical and mental health of the people, especially the elderly, about 80% Patients infected with COVID have one or more long-term symptoms (level I evidence).
-
The FDA approved a second new drug to slow down Alzheimer's disease, lecanemab
Time of Update: 2023-02-02
"Unclear impactLecanemab is authorized under the FDA's "accelerated approval" pathway, which specializes in treating diseases with few treatments; It also does not require phase III clinical trial data.
-
Treatment of drug-resistant tuberculosis with gamma delta T cells with a cure rate of up to 87.5
Time of Update: 2022-11-14
756495 On December 15, 2021, Shenzhen Third People's Hospital/National Clinical Research Center for Infectious Diseases, Jinan University, Guangdong Tuberculosis Control Center and other research teams carried out the world's first clinical study on γδ T cells in the treatment of drug-resistant tuberculosis, after three years, the research result "Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An.
-
Thousand-ton polystyrene pilot plant successfully started up
Time of Update: 2022-10-04
Construction of pilot plant In 2019, under the guidance of the science and technology department of the group company, Beihua Institute, together with Shanghai Engineering Company, Maoming Petrochemical, Zhejiang University and East China University of Science and Technology, developed a thousand-ton polystyrene technology, and adopted this technology in Zhanjiang Xinzhongmei Chemical Company.
-
The status quo of the smart car industry The development trend of the smart car industry
Time of Update: 2022-09-28
By 2025, master the overall technology of autonomous driving and various key technologies, establish a relatively complete independent research and development system, production supporting system and industrial group of intelligent networked vehicles, and basically complete the transformation and upgrading of the automobile industry .
-
A new tool to determine whether dilated cardiomyopathy has a genetic origin
Time of Update: 2022-09-21
Dr. García-Pavía and Dr. Luis EscobarScientists have developed a software application that can predict the possibility that dilated cardiomyopathy is caused by a genetic mutation.
Dr. García-Pavía and Dr. Luis EscobarScientists have developed a software application that can predict the possibility that dilated cardiomyopathy is caused by a genetic mutation.
-
Chongming Island 2009-2021 prevalence of multidrug resistance in Escherichia coli of food animal origin
Time of Update: 2022-09-20
The World Health Organization has proposed that antimicrobial resistance (AMR) is one of the most serious threats to human health in this century, especially in the context of the "post-antibiotic era
-
2021 Food Safety and Health Myth List Officially Released
Time of Update: 2022-09-20
(Editor Li Chuang) Food safety has attracted much attention under the normalization of the epidemic, but various rumors related to food safety have occurred from time to time, causing consumers "anxiety on the tip of the tongue" .
-
Walking at the grassroots level into the enterprise Zhang Wei, president of the China Drug Supervision and Administration Research Association, and his party came to Qianhui for research and guidance
Time of Update: 2022-09-07
On the afternoon of August 19, 2022, Zhang Wei, president of the China Drug Administration and Research Association and former secretary general of the State Pharmacopoeia Commission, Shi Liqiang, vi
-
Science Sub-Journal: Ouyang Bo's team reveals the molecular mechanism of cholesterol regulating PD-L1 stability
Time of Update: 2022-09-07
So, is there a direct link between high levels of cholesterol in tumor cells and highly expressed PD-L1, and does cholesterol play a regulatory role in PD-L1?Recently, the Ouyang Bo Research Group of the Center for Excellence in Molecular and Cell Science (Institute of Biochemistry and Cell Biology) of the Chinese Academy of Sciences published a research paper entitled Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs in the journal Science Advances online.
-
The South China Botanical Garden established a new genus of Zingiberaceae - Parahellenia
Time of Update: 2022-09-07
In order to further explore the phylogenetic relationship of this genus, Xia Nianhe's research team from the Plant Science Research Center of the South China Botanical Garden, Chinese Academy of Sciences sampled most of the species of Lettuce genus in China and Vietnam, and reconstructed lettuce using the chloroplast genome and two chloroplast gene fragments.
-
Clinical research report of Car-T cell therapy
Time of Update: 2022-08-30
CAR-T cell clinical development guidelines issued by FDA The clinical research work of new drugs should be oriented from clinical value, and drug research and development should be carried out around the needs of patients .
-
Daewoong Pharmaceutical Announces U.S. FDA Approval of its IND Application for DWP213388, the First-in-Class Oral, Irreversible, Dual-Acting Antifungal Drug for the Treatment of Autoimmune Diseases
Time of Update: 2022-08-20
, Ltd —DWP213388 is the first-in-class dual-target inhibitor that simultaneously inhibits pathogenic T cells and B cells in various autoimmune diseases SEOUL, South Korea, Aug. 15, 2022 /PRNewswire/ -- Daewoong Pharmaceutical, a publicly listed South Korean company that develops, manufactures and sells pharmaceuticals globally, announced today that the company's Investigational New Drug (IND) application has been approved in the U.
-
"Black Technology" Comes Out
Time of Update: 2022-08-15
Compared with plasmid-dependent unassisted systems, the production of rAAV2 using TESSA™ technology can increase vector yield by approximately 40 times ; in terms of quality, AAV vectors increase the cumulative transfection capacity of cells with the gene of interest by more than 2400 times (based on TESSA).
